ArticleCommunications biology2024

CRISPR/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.